# VIGABATRIN
> **ANDA210042** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2022-06-22
## Drug
- **FDA Application Number:** ANDA210042
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VIGABATRIN
- **Generic name:** VIGABATRIN
- **Active ingredients:** VIGABATRIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** AMNEAL PHARMS
- **Manufacturer:** Amneal Pharmaceuticals NY LLC
- **First approval:** 2022-06-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210042)
---
*AI Analytics · CC0 1.0*